Guang‐Nian Zhao

In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19

Xiao-Jing Zhang, Juan‐Juan Qin, Xu Cheng et al. · Cell Metabolism · 2020 · 492 citations · Full text

Reduced Risk, Preventive Medicine, Long Covid +12

Tmbim1 is a multivesicular body regulator that protects against non-alcoholic fatty liver disease in mice and monkeys by targeting the lysosomal degradation of Tlr4

Guang‐Nian Zhao, Peng Zhang, Jun Gong et al. · Nature Medicine · 2017 · 149 citations

Inflammation, Metabolic Syndrome, Autoimmune Disease +13

The Neutrophil-to-Lymphocyte Ratio Determines Clinical Efficacy of Corticosteroid Therapy in Patients with COVID-19

Jingjing Cai, Haomiao Li, Changjiang Zhang et al. · Cell Metabolism · 2021 · 132 citations · Full text

Clinical Immunology, Granulocyte, Covid-19 Pandemic +4

Hepatocyte TRAF3 promotes liver steatosis and systemic insulin resistance through targeting TAK1-dependent signalling

Pi‐Xiao Wang, Xiao‐Jing Zhang, Pengcheng Luo et al. · Nature Communications · 2016 · 121 citations · Full text

Targeting TRAF3 signaling protects against hepatic ischemia/reperfusions injury

Junfei Hu, Xue‐Hai Zhu, Xiao‐Jing Zhang et al. · Journal of Hepatology · 2015 · 92 citations

Inflammation, Signal Transduction, Hepatology +10